1 Tiger Global Novo Nordisk - ADR Trades
Tiger Global acquired 635 Thousand Novo Nordisk - ADR shares worth $57.7 Million. That's 0.49% of their equity portfolio (27th largest holding). The investor's estimated purchase price is $104 Million, resulting in a loss of 44%.
News about Novo Nordisk - ADR and Tiger Global
How Venomous Lizard Played Crucial Role In Development Of Weight Loss Drug Ozempic
In 1984, Dr. Daniel Drucker , an endocrinologist from the University of Toronto , made a groundbreaking discovery that would later revolutionize diabetes tre...
Novo Nordisk CEO And SVP On Ozempic And Wegovy
Following is the unofficial transcript of a CNBC interview with Novo Nordisk A/S (NYSE:NVO) CEO Lars Fruergaard Jørgensen, Novo Nordisk A/S Global Drug Disco...
Generic Pharmaceuticals Global Market Report 2023
Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.), Sun Pharmaceutical,...
3 Global Stocks to Buy to Get Around America’s Slowdown
If you’ve been avoiding stocks during the past few months in order to prevent yourself from making any more mistakes after 2022’s bloodbath and you’re lookin...